Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Payables (2016 - 2025)

Haemonetics (HAE) has 16 years of Payables data on record, last reported at $48.7 million in Q4 2025.

  • For Q4 2025, Payables fell 22.7% year-over-year to $48.7 million; the TTM value through Dec 2025 reached $48.7 million, down 22.7%, while the annual FY2025 figure was $67.0 million, 8.67% down from the prior year.
  • Payables reached $48.7 million in Q4 2025 per HAE's latest filing, down from $61.7 million in the prior quarter.
  • Across five years, Payables topped out at $80.2 million in Q3 2023 and bottomed at $45.0 million in Q4 2021.
  • Average Payables over 5 years is $61.1 million, with a median of $61.6 million recorded in 2022.
  • Peak YoY movement for Payables: soared 36.73% in 2022, then tumbled 40.19% in 2025.
  • A 5-year view of Payables shows it stood at $45.0 million in 2021, then surged by 41.81% to $63.8 million in 2022, then fell by 10.86% to $56.8 million in 2023, then increased by 10.81% to $63.0 million in 2024, then fell by 22.7% to $48.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $48.7 million in Q4 2025, $61.7 million in Q3 2025, and $46.0 million in Q2 2025.